London: Globally acknowledged medical journal publisher Elsevier has launched a GenAI tool, ScienceDirect AI, designed to reduce the time spent on literature reviews during research projects and help researchers generate accurate summaries instantly.
Citing several studies, Elsevier stated that researchers spend 25-35 per cent of their time sifting through literature, a challenge that can be overcome by leveraging advancements like GenAI.
ScienceDirect AI surfaces insights from the world’s largest corpus of peer-reviewed full-text articles and book chapters. It has been tested by more than 30,000 researchers and librarians from 70 universities and R&D-intensive corporations, Elsevier said in a release.
Judy Verses, President, Academic and Government Markets, Elsevier said: “Feedback from users worldwide suggests ScienceDirect AI could be a game changer for researchers who are grappling with information overload and want to get accurate insights they can rely on — fast.”
“ScienceDirect is the platform of choice globally for millions of researchers, so this new generative AI tool will seamlessly integrate into their current ways of working, enabling them to dedicate more time to research and achieve results,” Verses added.
ScienceDirect AI is designed to generate instant and accurate summaries, highlight key findings, and provide references to support the reproducibility and integrity of research.
Elsevier is a 140-year-old company that publishes more than 3,000 scientific journals and iconic reference books, including leading titles such as Cell Press, The Lancet, and Gray’s Anatomy.
